×
About 2,085 results

ALLMedicine™ Hirsutism Center

Research & Reviews  641 results

Antiandrogenic activity of Riboflavin 5'-phosphate (FMN) in 22Rv1 and LNCaP human prost...
https://doi.org/10.1016/j.ejphar.2022.174743
European Journal of Pharmacology; Choi YH, Kim J et. al.

Jan 10th, 2022 - The androgen receptor is a hormone activated transcription factor that regulates the development and maintenance of male characteristics and represents one of the most well-established drug targets, being implicated not only in prostate cancer but...

The effects of statins on hyperandrogenism in women with polycystic ovary syndrome: a s...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686603
Reproductive Biology and Endocrinology : RB&E; Chen J, Huang C et. al.

Dec 22nd, 2021 - Several clinical studies showed that statins were potential to treat polycystic ovary syndrome (PCOS). Through comprehensive search PubMed, EMBASE, the Web of Science, BIOSIS, the ClinialTrails.gov, and the Cochrane Library database up to 14 Feb 2...

Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in Cornelia de Lange Syndrome
https://clinicaltrials.gov/ct2/show/NCT04381897

Dec 21st, 2021 - Cornelia de Lange syndrome (CdLS) is a genetic condition caused by mutations in cohesin-related genes, mostly notably NIPBL. The CdLS phenotype includes physical features such as typical facies, limb abnormalities, short stature, and hirsutism as ...

A case report of ovarian granulosa cell tumor in patient with polycystic ovarian syndrome.
https://doi.org/10.1097/MD.0000000000028261
Medicine Kim YS, Lee JH

Dec 18th, 2021 - Granulosa cell tumors (GCTs) account for less than 2% of all ovarian malignancies and are the second most common ovarian sex cord stromal tumors after fibroma/thecomas.GCTs occur most frequently in postmenopausal women with a peak age of 50 to 55,...

Effects of Mixed of a Ketogenic Diet in Overweight and Obese Women with Polycystic Ovar...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656706
International Journal of Environmental Research and Publi... Cincione RI, Losavio F et. al.

Dec 11th, 2021 - Polycystic ovary syndrome (PCOS) is a commonly occurring endocrine disorder characterized by hirsutism, anovulation, and polycystic ovaries. Often comorbid with insulin resistance, dyslipidemia, and obesity, it also carries significant risk for th...

see more →

Guidelines  3 results

Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clin...
https://doi.org/10.1210/jc.2018-00241
The Journal of Clinical Endocrinology and Metabolism; Martin KA, Anderson RR et. al.

Mar 10th, 2018 - To update the "Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline," published by the Endocrine Society in 2008. The participants include an Endocrine Society-appointed task force of seven...

Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Andro...
https://doi.org/10.1093/humupd/dmr042
Human Reproduction Update; Escobar-Morreale HF, Carmina E et. al.

Nov 9th, 2011 - Hirsutism, defined by the presence of excessive terminal hair in androgen-sensitive areas of the female body, is one of the most common disorders in women during reproductive age. We conducted a systematic review and critical assessment of the ava...

Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clin...
https://doi.org/10.1210/jc.2007-2437
The Journal of Clinical Endocrinology and Metabolism; Martin KA, Chang RJ et. al.

Feb 7th, 2008 - Our objective was to develop clinical practice guidelines for the evaluation and treatment of hirsutism in premenopausal women. The Task Force was composed of a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society...

see more →

Drugs  25 results see all →

Clinicaltrials.gov  39 results

Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in Cornelia de Lange Syndrome
https://clinicaltrials.gov/ct2/show/NCT04381897

Dec 21st, 2021 - Cornelia de Lange syndrome (CdLS) is a genetic condition caused by mutations in cohesin-related genes, mostly notably NIPBL. The CdLS phenotype includes physical features such as typical facies, limb abnormalities, short stature, and hirsutism as ...

Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women
https://clinicaltrials.gov/ct2/show/NCT01889199

Nov 9th, 2021 - Aim 1. Examine mechanisms of subcutaneous abdominal adipose (fat) development in normal-weight PCOS women vs. BMI- and age-matched normal (control) women. Subjects and clinical assessment: We will recruit 16 lean (18.5-25 kg/M2) PCOS subjects and ...

Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)
https://clinicaltrials.gov/ct2/show/NCT04355572

Oct 8th, 2021 - Patients referred to the pediatric endocrinology clinic or adolescent gynecology clinic at Yale New Haven Children Hospital with a primary complaint of hirsutism, acne, or amenorrhea and/or oligomenorrhea persisting 2 years after their menarche wi...

Evaluation of Vitamin D in Women With PCOS and Sexual Dysfunction
https://clinicaltrials.gov/ct2/show/NCT02865187

Oct 7th, 2021 - BACKGROUND: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among reproductive age women with a prevalence as high as 15% using Rotterdam diagnostic criteria.1 PCOS is a heterogeneous clinical disorder characterized primaril...

Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age
https://clinicaltrials.gov/ct2/show/NCT03905941

Sep 28th, 2021 - This is a randomized, controlled, double-blinded, crossover study. The investigators will recruit women with PCOS in ages 40-49 yo. Subjects will be randomized to either receive metformin (2000 mg daily) or low dose oral contraceptives (OCs: 20 mc...

see more →

News  114 results

FDA Approves Levoketoconazole for Cushing Syndrome
https://www.medscape.com/viewarticle/965989

Jan 4th, 2022 - The US Food and Drug Administration has approved levoketoconazole (Recorlev, Xeris Biopharma) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not possible or was not curative. Endogenous Cushin...

FDA OKs First Proteinuria Drug for IgA Nephropathy
https://www.medpagetoday.com/nephrology/generalnephrology/96235

Dec 16th, 2021 - The FDA granted accelerated approval for the first drug to reduce proteinuria in primary immunoglobulin A (IgA) nephropathy, the agency announced on Wednesday. The delayed released budesonide (Tarpeyo) capsules are indicated to lower increased pro...

3 cases of hormone therapy optimized to match the patient problem
https://www.mdedge.com/obgyn/article/242599/gynecology/3-cases-hormone-therapy-optimized-match-patient-problem
Robert L. Barbieri, MD

Jul 7th, 2021 - There are dozens of medications containing combinations of estrogen and progestin. I am often confused by the bewildering proliferation of generic brand names used to describe the same estrogen-progestin (E-P) regimen.

Polycystic Ovary Syndrome: It’s Not Just About Fertility
https://www.medscape.com/viewarticle/951631

May 21st, 2021 - Polycystic ovary syndrome, the most common endocrinopathy and most common cause of female infertility, affects 8%-13% of reproductive-aged women. PCOS has a profound impact on a woman’s life yet its diagnosis and management remain confusing despit...

Polycystic ovary syndrome: It’s not just about fertility
https://www.mdedge.com/obgyn/article/240396/reproductive-endocrinology/polycystic-ovary-syndrome-its-not-just-about
Mark P. Trolice, MD

May 20th, 2021 - Polycystic ovary syndrome, the most common endocrinopathy and most common cause of female infertility, affects 8%-13% of reproductive-aged women. PCOS has a profound impact on a woman’s life yet its diagnosis and management remain confusing despit.

see more →

Patient Education  12 results see all →